Condition: Advanced Chronic Liver Disease · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
The goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advanced chronic liver disease. The main question it aims to answer are: \- what are the cut-off values for non-invasive tests (NITs) (including LSM, SSM) that predict the presence and occurrence of hepatic decompensation in individuals with advanced chronic liver disease? Participants will undergo regular study visits involving non-invasive tests (LSM, SSM) and assessments to monitor hepatic decompensation over the study period.
This description comes directly from the study's public registry record.
Amine Benmassaoud, MD · 514-934-1934 · amine.benmassaoud@mcgill.ca
Olivia Geraci, BSc · 514-934-1934 · olivia.geraci@muhc.mcgill.ca
Always discuss trial participation with your own doctor first.
| McGill University Health Centre | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06181409